Gingival carcinogenicity in female Harlan Sprague-Dawley rats following two-year oral treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin and dioxin-like compounds. 2005

Katsuhiko Yoshizawa, and Nigel J Walker, and Micheal P Jokinen, and Amy E Brix, and Donald M Sells, and Tiwanda Marsh, and Michael E Wyde, and Denise Orzech, and Joseph K Haseman, and Abraham Nyska
Laboratory of Experimental Pathology, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709, USA.

We evaluated gingival toxicities induced by chronic exposure of female Harlan Sprague-Dawley rats to dioxin and dioxin-like compounds (DLCs) and compared them to similarly induced oral lesions reported in the literature. This investigation represents part of an ongoing initiative of the National Toxicology Program to determine the relative potency of chronic toxicity and carcinogenicity of polychlorinated dioxins, furans, and biphenyls. For two years, animals were administered by gavage 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD); 3,3',4,4',5-pentachlorobiphenyl (PCB126); 2,3,4,7,8-pentachlorodibenzofuran (PeCDF); 2,2',4,4',5,5'-hexachlorobiphenyl (PCB153); a tertiary mixture of TCDD, PCB126, and PeCDF; a binary mixture of PCB126 and 153; or a binary mixture of PCB126 and 2,3',4,4',5-pentachlorobiphenyl (PCB118); control animals received corn oil-acetone vehicle (99:1) alone. A full complement of tissues, including the palate with teeth, was examined microscopically. In the groups treated with TCDD and the mixtures of TCDD, PCB126, and PeCDF; PCB126 and 153; and PCB126 and 118, the incidences of gingival squamous hyperplasia increased significantly. Moreover, in the groups treated with TCDD, PCB126, and the mixture of PCB126 and 153, squamous cell carcinoma (SCC) in the oral cavity increased significantly. This investigation constitutes the first report documenting that chronic administration of dioxin-like PCBs can induce gingival SCC in rats. These results indicate that dioxin and DLCs target the gingiva of the oral cavity, in particular the junctional epithelium of molars.

UI MeSH Term Description Entries
D006965 Hyperplasia An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells. Hyperplasias
D011078 Polychlorinated Biphenyls Industrial products consisting of a mixture of chlorinated biphenyl congeners and isomers. These compounds are highly lipophilic and tend to accumulate in fat stores of animals. Many of these compounds are considered toxic and potential environmental pollutants. PCBs,Polychlorinated Biphenyl,Polychlorobiphenyl Compounds,Biphenyl, Polychlorinated,Biphenyls, Polychlorinated,Compounds, Polychlorobiphenyl
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D004147 Dioxins A family of compounds that contain the 1,4-dioxin structure. Many specific dioxin derivatives are listed as CARCINOGENS; TERATOGENS; or MUTAGENS. Dioxin
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D005260 Female Females
D005881 Gingiva Oral tissue surrounding and attached to TEETH. Gums,Interdental Papilla,Papilla, Interdental,Gum
D005887 Gingival Neoplasms New abnormal growth of tissue in the GINGIVA. Epulis, Congenital,Congenital Epulides,Congenital Epulis,Epulides, Congenital,Neoplasms, Gingival,Gingival Neoplasm,Neoplasm, Gingival
D000072317 Polychlorinated Dibenzodioxins Dibenzodioxin derivatives that contain multiple chloride atoms bound to the benzene ring structures. TCDD,Tetrachlorodibenzodioxin,2,3,7,8-Tetrachlorodibenzo-p-dioxin,Chlorinated Dibenzo-p-dioxins,Dibenzo(b,e)(1,4)dioxin, 2,3,7,8-tetrachloro-,PCDD,Polychlorinated Dibenzo-p-dioxins,Polychlorinated Dibenzodioxin,Polychlorodibenzo-4-dioxin,Polychlorodibenzo-p-dioxin,Tetrachlorodibenzo-p-dioxin,Chlorinated Dibenzo p dioxins,Dibenzo-p-dioxins, Chlorinated,Dibenzo-p-dioxins, Polychlorinated,Dibenzodioxin, Polychlorinated,Dibenzodioxins, Polychlorinated,Polychlorinated Dibenzo p dioxins,Polychlorodibenzo 4 dioxin,Polychlorodibenzo p dioxin,Tetrachlorodibenzo p dioxin

Related Publications

Katsuhiko Yoshizawa, and Nigel J Walker, and Micheal P Jokinen, and Amy E Brix, and Donald M Sells, and Tiwanda Marsh, and Michael E Wyde, and Denise Orzech, and Joseph K Haseman, and Abraham Nyska
June 2004, Environmental health perspectives,
Katsuhiko Yoshizawa, and Nigel J Walker, and Micheal P Jokinen, and Amy E Brix, and Donald M Sells, and Tiwanda Marsh, and Michael E Wyde, and Denise Orzech, and Joseph K Haseman, and Abraham Nyska
April 2000, Toxicological sciences : an official journal of the Society of Toxicology,
Katsuhiko Yoshizawa, and Nigel J Walker, and Micheal P Jokinen, and Amy E Brix, and Donald M Sells, and Tiwanda Marsh, and Michael E Wyde, and Denise Orzech, and Joseph K Haseman, and Abraham Nyska
January 2004, Toxicologic pathology,
Katsuhiko Yoshizawa, and Nigel J Walker, and Micheal P Jokinen, and Amy E Brix, and Donald M Sells, and Tiwanda Marsh, and Michael E Wyde, and Denise Orzech, and Joseph K Haseman, and Abraham Nyska
June 1995, Toxicology and applied pharmacology,
Katsuhiko Yoshizawa, and Nigel J Walker, and Micheal P Jokinen, and Amy E Brix, and Donald M Sells, and Tiwanda Marsh, and Michael E Wyde, and Denise Orzech, and Joseph K Haseman, and Abraham Nyska
October 2006, Molecular nutrition & food research,
Katsuhiko Yoshizawa, and Nigel J Walker, and Micheal P Jokinen, and Amy E Brix, and Donald M Sells, and Tiwanda Marsh, and Michael E Wyde, and Denise Orzech, and Joseph K Haseman, and Abraham Nyska
June 1992, Regulatory toxicology and pharmacology : RTP,
Katsuhiko Yoshizawa, and Nigel J Walker, and Micheal P Jokinen, and Amy E Brix, and Donald M Sells, and Tiwanda Marsh, and Michael E Wyde, and Denise Orzech, and Joseph K Haseman, and Abraham Nyska
May 1995, Toxicology and applied pharmacology,
Katsuhiko Yoshizawa, and Nigel J Walker, and Micheal P Jokinen, and Amy E Brix, and Donald M Sells, and Tiwanda Marsh, and Michael E Wyde, and Denise Orzech, and Joseph K Haseman, and Abraham Nyska
January 2003, Cardiovascular toxicology,
Katsuhiko Yoshizawa, and Nigel J Walker, and Micheal P Jokinen, and Amy E Brix, and Donald M Sells, and Tiwanda Marsh, and Michael E Wyde, and Denise Orzech, and Joseph K Haseman, and Abraham Nyska
August 1995, Toxicology letters,
Katsuhiko Yoshizawa, and Nigel J Walker, and Micheal P Jokinen, and Amy E Brix, and Donald M Sells, and Tiwanda Marsh, and Michael E Wyde, and Denise Orzech, and Joseph K Haseman, and Abraham Nyska
August 2011, Talanta,
Copied contents to your clipboard!